Clinical Trials Sponsored by Leo W. Jenkins Cancer Center

Total 855 results

H. Lee Moffitt Cancer Center and Research Institute

Terminated

Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer

Breast Cancer | Breast Cancer Female | Breast Adenocarcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Caregiver Protocol for Remotely Improving, Monitoring, and Extending Quality of Life (C-PRIME)

Quality of Life | Stress | Sleep Disturbance

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia

Hyperglycemia

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Addressing Barriers to Palliative Care Use in Bladder Cancer

Muscle-Invasive Bladder Carcinoma | Bladder Cancer Stage II | Bladder Cancer Stage III | Bladder Cancer Stage IV

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)

Multiple Myeloma

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease

Graft Versus Host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Colorectal Cancer Awareness, Research, Education and Screening (CARES)

Colorectal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1

Breast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | HER-2 Gene Amplification | Breast Cancer Female | HER2 Positive Breast Carcinoma | HER-2 Protein Overexpression

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Evaluating Biobanking Educational Tools

Neoplasm

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population

Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors

Lung Neuroendocrine Neoplasm | Gastroenteropancreatic Neuroendocrine Tumor

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer

Thyroid Cancer, Medullary | Thyroid Cancer | Papillary Thyroid Cancer | Differentiated Thyroid Cancer | Poorly Differentiated Thyroid Gland Carcinoma | Follicular Thyroid Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer

Liver Cancer | Hepatocellular Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

Breast Cancer | Breast Neoplasms | Breast Cancer, Male | Breast Cancer, Female

United States
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate Cancer

Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute

Completed

To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid

Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung

Lung Cancer | Adenocarcinoma of the Lung
H. Lee Moffitt Cancer Center and Research Institute

Completed

Effects of Yoga and Cardiovascular Exercise on Smoking Motivation

Tobacco Dependence

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection

Cancer of the Urinary Tract

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas

Glioma | Astrocytoma | Oligodendroglioma

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Pilot Study of Regional Lung Ventilation

Non-small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer

Pancreatic Tumor
H. Lee Moffitt Cancer Center and Research Institute

Terminated

GTX-RT in Borderline Resectable Pancreatic Cancer

Pancreatic Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX

Mucositis | Graft-versus-host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

Rectal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Study of CG0070 After Transurethral Resection in Patients With IR NMIBC

Non-muscle Invasive Bladder Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

REFLECT: Reproductive Education and Fertility Links for Cancer Treatment (REFLECT)

Reproductive Behavior

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Pilot Trial of Adaptive Radiotherapy Boost for HNSCC

Head and Neck Cancer | Squamous Cell Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Enhancing Cancer Survivorship With Pickleball

Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

Benign Prostatic Hyperplasia | Prostate Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk (B-SUPER)

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

Prostate Cancer | Advanced Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer

Non Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Lung Cancer, Nonsmall Cell

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients

Depressive Disorder | Depression | Cancer | Generalized Anxiety Disorder | Anxiety | Major Depressive Disorder

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC

Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Stage IV Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage IIIB | EGFR Negative Non-Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors

Renal Cell Carcinoma | Non-Small Cell Lung Cancer | NSCLC | Solid Tumor | Metastatic Cancer | Squamous Cell Carcinoma of the Head and Neck | Urothelial Carcinoma | Squamous Cell Carcinoma | Recurrent Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery

GI Cancer | Nutritional Deficiency

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE

Hepatocellular Carcinoma | Liver Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers

Hepatitis C Virus Infection | Colorectal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas

Malignant Glioma

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults

HPV Vaccine Knowledge

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma

Angiosarcoma of Skin

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma

Rectal Cancer | Rectal Adenocarcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas

Pancreatic Cancer | Gastro-enteropancreatic Neuroendocrine Tumor | Neuroendocrine Carcinomas of Pancreas | Islet Cell Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection

Dysphagia

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis

Graft-Versus-Host-Disease

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer

Prostate Cancer

United States

Clinical Trials Sponsored by Leo W. Jenkins Cancer Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations